Compare Bank of Montreal (BMO) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank of Montreal vs 10X Genomics Inc — how do they compare? Bank of Montreal trades at $180.98 (market cap $124.81B), while 10X Genomics Inc trades at $45.99 (market cap $5.30B). The key difference: Bank of Montreal is far larger — about 23.5× 10X Genomics Inc's market cap, and Bank of Montreal pays a 2.77% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| BMO | TXG | |
|---|---|---|
Market Cap | $124.81B | $5.30B |
Sector | Financials | Health |
52-Week High | $180.86 | $45.80 |
52-Week Low | $110.44 | $11.34 |
Dividend Yield | 2.77% | — |
Enterprise Value | — | $4.85B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bank of Montreal
Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
Read more on BMO →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
